Acute PresentatiOn of CoLorectaL Cancer: an internatiOnal Snapshot
APOLLO
1 other identifier
observational
2,000
1 country
1
Brief Summary
APOLLO (Acute PresentatiOn of CoLorectaL Cancer: an internatiOnal snapshot) is an international, multi-centre, prospective observational study which will address this need and aims to describe the operative and non-operative management of emergency presentations of colon and rectal cancer in an international cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2022
CompletedFirst Posted
Study publicly available on registry
December 7, 2022
CompletedStudy Start
First participant enrolled
January 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2023
CompletedFebruary 20, 2024
February 1, 2023
8 months
November 17, 2022
February 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome
Mortality since day of presentation
90-day
Secondary Outcomes (9)
Secondary outcome 1
30-day
Secondary outcome 2
30- and 90-day
Secondary outcome 3
30- and 90-day
Secondary outcome 4
30- and 90-day
Secondary outcome 5
90-day
- +4 more secondary outcomes
Study Arms (1)
Main Cohort
Consecutive adult patients (≥18 years of age) presenting acutely (i.e. unplanned and non-elective presentation to hospital for urgent or emergency reasons) for symptoms of known or unknown colorectal cancer assessed by hospital surgical teams. Patients should be included regardless of operative or non-operative management, and curative or palliative intent.
Eligibility Criteria
Consecutive adult patients (≥18 years of age) presenting acutely (i.e. unplanned and non-elective presentation to hospital for urgent or emergency reasons) for symptoms of known or unknown colorectal cancer assessed by hospital surgical teams. Patients should be included regardless of operative or non-operative management, and curative or palliative intent.
You may qualify if:
- Patient pathology: Patients admitted to the hospital acutely with primary colon AND/OR rectal adenocarcinoma and referred to general/colorectal surgical departments:
- Patients who are operated on for curative/palliative treatment of colorectal cancer
- Patients who are referred to general surgery for assessment (irrespective of if they proceed to surgery)
- New diagnoses of colorectal cancer
- Extent of cancer: All patients including extra-abdominal metastatic, intra-abdominal metastatic and non-metastatic disease
- Known cancer: Patients presenting for the first time with colorectal cancer AND/OR known colorectal cancer diagnosis with progression of disease. i.e. obstruction of known colorectal cancer
- Patient presentation: Symptomatic presentation of colorectal cancer i.e. large bowel obstruction, haemorrhage, perforation
You may not qualify if:
- Presenting for side effects of cancer treatment
- Patients with secondary cancers
- Previously included in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aberdeen Royal Infirmary
Aberdeen, Ireland, United Kingdom
Related Publications (1)
EuroSurg Collaborative and STARSurg Collaborative. Global Use and Outcomes of Endoscopic Stenting in Acute Malignant Left-Sided Colonic Obstruction: A Secondary Analysis of APOLLO, An International, Prospective Cohort Study. Dis Colon Rectum. 2025 Dec 1;68(12):1458-1467. doi: 10.1097/DCR.0000000000003960. Epub 2025 Oct 10.
PMID: 41070782DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2022
First Posted
December 7, 2022
Study Start
January 16, 2023
Primary Completion
September 11, 2023
Study Completion
November 11, 2023
Last Updated
February 20, 2024
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share
Centre-summaries will be made available to respective centres for audit purposes.